Sign in
ROQ Stock Price, Chart, Stats & News
Roquefort Therapeutics plc
Save
Roquefort Therapeutics plc (ROQ) does not currently pay a dividend.
155,540
Market cap
–
Current P/E
–
Forward P/E
ROQ chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Roquefort Therapeutics plc functions as a biotechnology firm, focusing its efforts on the discovery and development of innovative pharmaceutical treatments. The company's primary research objective is to develop therapies that target Midkine, a circulating growth factor protein and pro-inflammatory mediator, for applications in cancer treatment. Established in 2020, Roquefort Therapeutics plc has its main operations based in London, United Kingdom.
Similar securities
Based on sector and market capitalization
Report issue